Enterome vs ProEncia Biotechnology
Enterome vs ProEncia Biotechnology, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and ProEncia Biotechnology on 17/100.
Where each one leads
Enterome
- our overall score: 60/100 against 17/100
- domain rating: 46/100 against 5/100
- headcount: 33 against 5
- LinkedIn following: 16,846 against 55
ProEncia Biotechnology
- agent readiness: 40/100 against 21/100
At a glance
| Measure | Enterome | ProEncia Biotechnology |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Developing next-generation, non-invasive periodontal disease treatments. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B2C |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2012 | 2019 |
| Headquarters | Paris, France | Minneapolis, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | ProEncia Biotechnology |
|---|---|---|
| Employees | 33 | 5 |
| Total funding | $124M | Not published |
| Latest round | Later Stage VC | Pre-Seed |
| LinkedIn followers | 16,846 | 55 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | ProEncia Biotechnology |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 17/100 |
| Traction | 55/100 | 8/100 |
| Team | 70/100 | Not published |
| Search visibility | 34/100 | 22/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 5/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | ProEncia Biotechnology |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Squarespace |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4, Segment | Not detected |
Enterome vs ProEncia Biotechnology: common questions
Which is better, Enterome or ProEncia Biotechnology?
On our 0-100 score Enterome rates higher (60/100 against 17/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Enterome and ProEncia Biotechnology compare on the numbers?
Enterome leads on our overall score (60/100 against 17/100), domain rating (46/100 against 5/100), headcount (33 against 5), LinkedIn following (16,846 against 55). ProEncia Biotechnology leads on agent readiness (40/100 against 21/100).
Read the full Enterome review and pricing or the ProEncia Biotechnology review and pricing. You can also browse other Enterome alternatives we track.